Literature DB >> 11857100

Transanal endoscopic microsurgery (TEM) for minimally invasive resection of rectal adenomas and "Low-risk" carcinomas (uT1, G1 - 2).

C Langer1, T Liersch, P Markus, M Süss, M Ghadimi, L Füzesi, H Becker.   

Abstract

Transanal endoscopic microsurgery (TEM) presents a minimally invasive procedure for local removal of large rectal adenomas (>/= 2 cm) and early, so called "low-risk" carcinomas (uT1, G1 - 2) in curative as well as of advanced tumors in palliative intent. Over a 6-year period 92 TEM excisions of rectal tumors were carried out including 91 patients with 56 adenomas, 35 carcinomas (9 pTis, 17 pT1, 5 pT2, 3 pT3, 1 Ca after snare diathermy) and one neurinoma. Two patients of the carcinoma group had to be reoperated by means of anterior resection due to false preoperative rectal ultrasound examination (2 x uT1--> pT2). 4 patients required palliative therapy on account of age or high morbidity. After a mean follow-up time of 23 months (adenomas 23 months, pT1 carcinoma 26 months and advanced tumors 38 months) we encountered a total of 7 complications, of which in 5 cases surgical reintervention was necessary (5,4 %). One 86-year-old patient with a pT2-carcinoma, who was unsuitable for low anterior resection due to a high morbidity risk, died from myocardial infarction after emergency reintervention caused by postoperative bleeding. To date, overall 9 recurrences occurred (9,8 %). In the specific target group of TEM (adenomas and pT1, G1-2 carcinomas) consisting of n = 83 cases, the overall recurrence rate was 7,2 %, of which 5,3 % were due to adenomas and 11,5 % due to carcinomas. After palliative excision 2 recurrences occurred. These results of transanal endoscopic microsurgery (TEM) indicate that this technique has a useful place in curative, as well as in palliative management of rectal tumors.

Entities:  

Mesh:

Year:  2002        PMID: 11857100     DOI: 10.1055/s-2002-20210

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  6 in total

1.  Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging.

Authors:  Chan Kyo Kim; Seung Hoon Kim; Ho Kyung Chun; Woo-Yong Lee; Seong-Hyeon Yun; Sang-Yong Song; Dongil Choi; Hyo Keun Lim; Min Ju Kim; Jongmee Lee; Soon Jin Lee
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

2.  Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study.

Authors:  F Stipa; A Burza; G Lucandri; M Ferri; A Pigazzi; V Ziparo; G Casula; S Stipa
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

3.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

Review 4.  Transanal endoscopic microsurgery: indications, results and controversies.

Authors:  Andre Roncon Dias; Caio Sergio Rizkallah Nahas; Carlos Frederico Sparapan Marques; Sergio Carlos Nahas; Ivan Cecconello
Journal:  Tech Coloproctol       Date:  2009-05-29       Impact factor: 3.781

5.  Harmonic long shears further reduce operation time in transanal endoscopic microsurgery.

Authors:  Pleun E A Hermsen; Ifesegun D Ayodeji; Wim H C Hop; Geert W M Tetteroo; Eelco J R de Graaf
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

6.  Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study).

Authors:  Frank J C van den Broek; Eelco J R de Graaf; Marcel G W Dijkgraaf; Johannes B Reitsma; Jelle Haringsma; Robin Timmer; Bas L A M Weusten; Michael F Gerhards; Esther C J Consten; Matthijs P Schwartz; Maarten J Boom; Erik J Derksen; A Bart Bijnen; Paul H P Davids; Christiaan Hoff; Hendrik M van Dullemen; G Dimitri N Heine; Klaas van der Linde; Jeroen M Jansen; Rosalie C H Mallant-Hent; Ronald Breumelhof; Han Geldof; James C H Hardwick; Pascal G Doornebosch; Annekatrien C T M Depla; Miranda F Ernst; Ivo P van Munster; Ignace H J T de Hingh; Erik J Schoon; Willem A Bemelman; Paul Fockens; Evelien Dekker
Journal:  BMC Surg       Date:  2009-03-13       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.